LIXIANA® – SIMPLE AND CONVENIENT ONCE-DAILY DOSING IN NVAF1
Once-daily LIXIANA® is convenient and simple for patients and prescribers
LIXIANA® offers the same once-daily dosing in NVAF1
No scheduled high-to-low dose transition at initiation LIXIANA® for VTE** patients1
Can be taken with or without food1
Low potential for interactions with drugs metabolised by cytochrome P4502
No routine anticoagulation level monitoring required.1
Clear guidance for use with specific P-gp inhibitors1
See guidance for switching patients to and from LIXIANA®
See guidance for treating special populations
See guidance for practical considerations
LIXIANA®, Summary of Product Characteristics.
Data on file, Daiichi Sankyo UK Limited, DOF-EDX15-001, June 2015.